Cohance Lifesciences Announces Board Meeting and Trading Window Status Update
Cohance Lifesciences Limited, formerly Suven Pharmaceuticals Limited, has scheduled a meeting of its Board of Directors to review critical financial results for the quarter ended June 30, 2026. The company also provided an update regarding the continuation of its trading window closure period for Designated Persons and their immediate relatives.The Board Meeting is set to take place on Wednesday, August 5, 2026. The primary agenda item for the meeting includes considering and approving the Unaudited Financial Results (both Standalone and Consolidated) for the company, which relate to the quarter that concluded on June 30, 2026.
In addition to the board meeting announcement, Cohance Lifesciences confirmed that the trading window will remain closed until August 7, 2026. This closure pertains to Designated Persons and their immediate relatives, following a previous communication regarding the cessation of trading activities.
COHANCE Stock Price Movement
As of 12:26 PM, shares of Cohance Lifesciences Limited are slipping by 2.25% in live trading, currently at ₹428.25 following a sharp intraday decline. The stock sees brisk activity as over 331,160 shares change hands during the ongoing market session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.